Other
Neoplasm by Cause
CI-CAN-00000032Explore in graph →
Non-malignant195 active trials4 approved drugs1 evidence items
- NCIt
- C27933
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000032Explore in graph →
Clinical trials
708 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06321627 | Radiosensitivity of HPV-related Tumors: Towards a Genomic Approach(ICARUS) | unknown | — | 100 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT04563013 | Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients | completed | N/A | 261 | Xidian UniversityOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT03407859 | Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL | unknown | Early Phase 1 | 100 | Zhujiang HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT05024955 | Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 15, 2024 | clinicaltrials |
| NCT04525222 | mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation | completed | Phase 1 | 242 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT00019188 | Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2024 | clinicaltrials |
| NCT02168140 | CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma | completed | Phase 1 | 16 | Wake Forest University Health SciencesOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT04297332 | Episodic Future Thinking and Future Thinking Priming for Smoking Cessation | terminated | N/A | 26 | Roswell Park Cancer InstituteOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT05936502 | Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer(EPIC-iENE DATA) | completed | — | 3,500 | Head and Neck Cancer International GroupOTHER | 8 | Feb 1, 2024 | clinicaltrials |
| NCT01769222 | Ipilimumab and Local Radiation for Selected Solid Tumors | terminated | Phase 1 | 3 | Stanford UniversityOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT01904136 | Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia | completed | Phase 1 / Phase 2 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT05582590 | Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers | not yet recruiting | Phase 1 | 36 | NexImmune Inc.INDUSTRY | 0 | Jan 16, 2024 | clinicaltrials |
| NCT06196190 | Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer | recruiting | — | 200 | Rambam Health Care CampusOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT05227027 | Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation | completed | N/A | 500 | University of California, San FranciscoOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT04744285 | Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette Smokers(COMET 2 3 1) | completed | N/A | 115 | Roswell Park Cancer InstituteOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT05393869 | Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults | completed | N/A | 2,849 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT05245487 | Danish Elder Lymphoma Patient Hematopoietic Investigation(DELPHI) | recruiting | — | 300 | Rigshospitalet, DenmarkOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT05577364 | Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients | unknown | Phase 1 / Phase 2 | 54 | Sun Yat-sen UniversityOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT05321940 | Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias | withdrawn | Phase 1 | 0 | Juan C. Ramos, MDOTHER | 0 | Dec 4, 2023 | clinicaltrials |
| NCT04267874 | Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study | completed | Early Phase 1 | 96 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT01523223 | Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies | completed | Phase 1 | 16 | Robert LowskyOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT01193842 | Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas | completed | Phase 1 / Phase 2 | 107 | National Cancer Institute (NCI)NIH | 1 | Nov 21, 2023 | clinicaltrials |
| NCT03961919 | Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant(FLAT-Auto) | completed | Phase 2 | 15 | Ciceri FabioOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT00924170 | Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Nov 14, 2023 | clinicaltrials |
| NCT04638465 | De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma | active not recruiting | — | 150 | Nebraska Methodist Health SystemOTHER | 1 | Nov 9, 2023 | clinicaltrials |
| NCT01823198 | Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies | completed | Phase 1 / Phase 2 | 63 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT03200236 | The Lung Screening, Tobacco and Health Project | completed | Phase 3 | 1,114 | Georgetown UniversityOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT04880837 | Human Papillomavirus Education Programs | completed | N/A | 12 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT03546101 | Early Detection of Epstein-Barr Virus Related Disease. | completed | — | 1,527 | University of AarhusOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04958434 | Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors | terminated | Phase 1 | 19 | Suzhou Transcenta Therapeutics Co., Ltd.INDUSTRY | 1 | Oct 23, 2023 | clinicaltrials |
| NCT03096782 | Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma | completed | Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT05329792 | L19IL2/L19TNF in Skin Cancer Patients(IntriNSiC) | unknown | Phase 2 | 70 | Philogen S.p.A.INDUSTRY | 3 | Oct 6, 2023 | clinicaltrials |
| NCT03404297 | Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya | completed | N/A | 30 | Indiana UniversityOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03480373 | Electronic Cigarette Use During Pregnancy | completed | — | 182 | UConn HealthOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04679675 | Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial(STEP) | completed | N/A | 32,771 | Kaiser PermanenteOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT06041061 | A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years | active not recruiting | Phase 3 | 18,000 | Sinocelltech Ltd.INDUSTRY | 1 | Sep 18, 2023 | clinicaltrials |
| NCT01336920 | Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma | completed | Phase 1 | 15 | University of NebraskaOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT03452332 | Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers | completed | Phase 1 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT02642965 | Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia | completed | Phase 1 / Phase 2 | 38 | Children's Oncology GroupNETWORK | 2 | Sep 8, 2023 | clinicaltrials |
| NCT01044745 | Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer | terminated | Phase 2 | 20 | University of NebraskaOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05996796 | Dry Run of the ScreenUrSelf Trial | completed | N/A | 38 | Universiteit AntwerpenOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05970627 | Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | not yet recruiting | Phase 2 | 30 | Yu jirenOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT03402230 | Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers | completed | Early Phase 1 | 49 | National Cancer Institute (NCI)NIH | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03272633 | Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies | terminated | Early Phase 1 | 2 | Rutgers, The State University of New JerseyOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT02822495 | Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies | no longer available | — | — | Atara BiotherapeuticsINDUSTRY | 0 | Jun 15, 2023 | clinicaltrials |
| NCT01378871 | A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma | terminated | Phase 2 | 1 | Amit VermaOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT03268993 | Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer | completed | N/A | 6 | University of PittsburghOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT04502524 | Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans | completed | Phase 1 | 53 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05231135 | A Registry Study on HIV-related Lymphoma | recruiting | — | 300 | Rotkreuzklinikum München gGmbHOTHER | 4 | Apr 6, 2023 | clinicaltrials |
| NCT02890368 | Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides | terminated | Phase 1 | 56 | PfizerINDUSTRY | 1 | Apr 5, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Mar 20, 2024source: clinicaltrials